News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Elbion AG Closes Additional $12.6 Million To Cap Series A At $44 Million


10/19/2005 5:09:50 PM

5/24/2005 Elbion AG, which is developing small molecules for inflammatory and central nervous system diseases, said it closed an additional EUR10 million ($12.6 million) to cap its Series A round at EUR35 million ($44 million).


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES